RELATIONSHIP BETWEEN SYMPTOMS AND HEALTH-RELATED QUALITY-OF-LIFE IN CHRONIC LUNG-DISEASE

被引：59

作者：

VIRAMONTES, JL ^{[1
]}

OBRIEN, B ^{[1
]}

机构：

[1] NATL AUTONOMOUS UNIV MEXICO,GEN HOSP MEXICO,CLIN EPIDEMIOL UNIT,MEXICO CITY,DF,MEXICO

来源：

JOURNAL OF GENERAL INTERNAL MEDICINE | 1994年 / 9卷 / 01期

关键词：

CHRONIC LUNG DISEASE; QUALITY OF LIFE; SYMPTOMS; DISEASE SEVERITY; SHORT FORM 36;

D O I：

10.1007/BF02599142

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The authors studied the relationship between patient self-reported symptoms and responses to a general measure of health-related quality of life [Short Form 36 (SF-36)] for 102 patients who had chronic lung disease [forced expiratory volume in one second (FEV(1)) <70%]. The primary diagnoses were chronic bronchitis, emphysema, and asthma; the mean age was 62 years, and 46% were women. Based upon Medical Research Council (MRC) symptom scores, the patients' disease severity was classified as mild (21%), moderate (22%), or severe (57%) The SF-36 scores differed significantly between disease severity groups in domains of health perception, physical functioning physical role, and energy. The SF-36 physical functioning and Oxygen Cost Diagram scores correlated well (r = 0.78). The authors conclude that SF-36 is a useful and valid measure of general health status in patients with chronic lung disorders.

引用

页码：46 / 48

页数：3

共 11 条

[1]

Guyatt G.H., Van Zarten S.J.O.V., Feeney D.H., Patrick D.L., Measuring quality of life in clinical trials: a taxonomy and review, Can Med Assoc J, 140, pp. 1441-8, (1989)

[2]

Aaronson N.J., Quality-of-life assessment in clinical trials: methodological issues, Controlled Clinical Trials, 10, pp. 195s-208s, (1989)

[3]

Guyatt G.H., Berman L.B., Townsend M., Pugsley S.O., Chambers L.W., A measure of quality of life for clinical trials in chronic lung disease, Thorax, 42, pp. 773-8, (1987)

[4]

Alonso J., Anto J.M., Gonzalez M., Fiz J.A., Izquierdo J., Morera J., Measurement of general health status of non-oxygen-dependent chronic obstructive pulmonary disease patients, Med Care, 30, (1992)

[5]

Ware J.E., Sherbourne C.D., The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection, Med Care, 30, pp. 473-83, (1992)

[6]

Samet J.M., A historical and epidemiologic perspective on respiratory symptoms questionnaires, Am J Epidemiol, 108, pp. 435-46, (1978)

[7]

Brooks SM (Chairman). Surveillance for respiratory hazards, Am Thorac Soc News, 8, pp. 12-6, (1982)

[8]

McGavin C.R., Artvinly M., Naoe H., McHardy G.J.R., Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease, BMJ, 2, pp. 241-3, (1978)

[9]

Stewart A.L., Greenfield S., Hays R.D., Et al., Functional status and well-being of patients with chronic conditions, JAMA, 262, pp. 907-13, (1989)

[10]

Brazier J.E., Harper R., Jones N.M.B., Et al., Validating the SF-36 health survey questionnaire: new outcome measure for primary care, BMJ, 305, pp. 160-4, (1992)

← 1 2 →